Estrogenic components for use in the treatment of neurological disorders
US9808470B2 · kind B2 · utility
2Cited by
3References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2015 |
| Grant date | Nov 7, 2017 |
| Priority date | — |
| Expiry date | Jan 11, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/57
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the prophylactic and therapeutic applications of certain estrogenic components, such as estetrol in neurological disorders, such as diffuse white matter injury.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.